Cleanup of former core business prompts Ambu to exit 40 markets
The original core area of anesthesia and patient monitoring will become a smaller part of Ambu in the years to come.
Ambu CEO Britt Meelby Jensen is in the process of cleaning up the anesthesia and patient monitoring business area, and thus the Danish medical device company is leaving 40 of the approximately 100 markets in which the company is currently represented with its products.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
